Novo Nordisk A S NVO Balance Sheet (2012-2019)

NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT
Reported Financials

Novo Nordisk A S Quarterly Balance Sheet

Periods 20 quarters
Latest Dec 2019

Novo Nordisk A S balance sheet data for the quarter ended Dec 2019. This balance sheet covers 20 quarters of results from Mar 2012 through Dec 2019, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019
Assets
Non-Current Assets
Property, Plant & Equipment (Net) 1.29B1.44B1.51B1.66B1.59B1.76B1.73B1.86B1.70B1.94B1.98B2.05B1.88B2.12B2.15B2.30B
Assets 70.34B77.06B91.80B
Liabilities
Non-Current Liabilities
Total Liabilities 27.77B36.77B44.83B
Shareholder's Equity
Common Equity 42.57B40.29B46.97B45.27B
Liabilities and Shareholders Equity 70.34B77.06B91.80B
Treasury Shares -0.02B0.02B0.01B-0.01B-0.01B-0.01B-0.01B-0.01B

Novo Nordisk A S Balance Sheet API

Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY